Skin cancer is a common type of cancer that can occur anywhere on the body Read to find out about the least expected areas ...
Air pollution might be playing an increasing role in causing the disease.
Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...
A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...
9d
News Medical on MSNStudy reveals how healthy stem cells transform into cancer cellsNearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the rate of new cases continues to rise.
A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.
Discover how a simple saliva test offers a painless and reliable method for early oral cancer detection, potentially ...
Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...
Bladder cancer often begins with subtle symptoms that are easy to overlook. The most common early sign is blood in the urine, a condition known as hematuria. In many cases, the blood may not always be ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...
9h
News Medical on MSNScottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results